SEC Form 4 · accession 0001104659-19-013436
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bryan Ball
Officer — Chief Quality Officer
Period of report
Mar 5, 2019
Accepted (ET)
Mar 7, 2019 · 6:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $16.96 | Mar 5, 2019 | A | 142,857 | A | Mar 5, 2020 | Mar 5, 2026 | Common Stock, par value $0.01 per share | 142,857 | 142,857 | D |
Explanation of responses
- F1The reporting person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and 6.025% on a quarterly basis thereafter.